Myeloma News and Research

RSS

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Brian Walker, Ph.D., with the Myeloma Center at the University of Arkansas for Medical Sciences has received a $542,486, three-year grant from the Leukemia & Lymphoma Society to look at changes in the DNA sequence that effects the development and advancement of multiple myeloma, a cancer of plasma cells in the blood.

12 Aug 2019

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

New research from the Hutchinson Institute for Cancer Outcomes Research- which is based at Fred Hutchinson Cancer Research Center- along with the University of Washington and the Seattle Cancer Care Alliance, identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.

19 Jul 2019

Rutgers researchers create new device to see if targeted cancer therapy is working

Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients.

17 Jul 2019

AI-enabled device detects if targeted chemotherapy is working

A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.

17 Jul 2019

Engineered stem cells offer new treatment for metastatic bone cancer

Engineered stem cells could help treat metastatic cancers in bone without killing normal surrounding bone.

9 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Have cancer, must travel: Patients left in lurch after hospital closes

One Monday in February, 65-year-old Karen Endicott-Coyan gripped the wheel of her black 2014 Ford Taurus with both hands as she made the hour-long drive from her farm near Fort Scott to Chanute.

1 Jul 2019

Multiple Sclerosis patients may have greater risk of developing cancer

New results of a 65-year follow-up study of nearly 7,000 Norwegian patients with Multiple Sclerosis suggest that patients may have a greater overall risk of developing cancer than the general population, with an especially high risk of cancer in respiratory organs, urinary organs and the central nervous system.

1 Jul 2019

Researchers exploit nanoparticles to develop test for early detection of different diseases

Investigators from Brigham and Women's Hospital are taking advantage of a unique phenomenon of nanoparticles to develop a test for early detection of different types of diseases, including cancer.

17 Jun 2019

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.

14 Jun 2019

Roswell Park physician leads effort to compile new multiple myeloma imaging guidelines

Just as newer drugs have significantly improved outcomes for patients with multiple myeloma in the past decade, newer imaging techniques are upgrading detection of the disease, leading to earlier treatment.

14 Jun 2019

Myeloma UK launches new research program to support patient-centric myeloma clinical trials

Myeloma UK is launching a new research program to continue support for patient-centric myeloma clinical trials in the UK, the UK Myeloma Research Alliance-Myeloma UK-Concept and Access Research Programme.

10 Jun 2019

Drug therapy may delay onset of myeloma symptoms, finds study

The largest randomized trial involving smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of myeloma symptoms, according to Mayo Clinic researchers.

3 Jun 2019

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia, have been shown to be effective when given together for high-risk and older patients with the disease, according to a study at The University of Texas MD Anderson Cancer Center.

30 May 2019

Myeloma News and Research

Cancer survivors could be at greater risk of cardiovascular diseases

Roswell Park receives more than $15 million in grants for cancer research

UAMS Myeloma Center receives $542,486 grant from Leukemia & Lymphoma Society

Study finds new way to help cancer doctors predict blood clots in patients with multiple myeloma

Rutgers researchers create new device to see if targeted cancer therapy is working

AI-enabled device detects if targeted chemotherapy is working

Engineered stem cells offer new treatment for metastatic bone cancer

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Have cancer, must travel: Patients left in lurch after hospital closes

Multiple Sclerosis patients may have greater risk of developing cancer

Researchers exploit nanoparticles to develop test for early detection of different diseases

Study identifies risk factors for cardiotoxicity with relapsed multiple myeloma therapy

Roswell Park physician leads effort to compile new multiple myeloma imaging guidelines

Myeloma UK launches new research program to support patient-centric myeloma clinical trials

Drug therapy may delay onset of myeloma symptoms, finds study

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Small molecule drug may help overcome ibrutinib resistance in mantle cell lymphona

Finding potential treatments for autoimmune diseases

DNA rearrangement may predict poor outcomes in multiple myeloma

Different types of myeloma need specific criteria diagnostic criteria

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News